Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses.
Elena CampioneAntonia RivieccioRuslana Gaeta ShumakGaetana CostanzaTerenzio CosioSara LambiaseVirginia GarofaloFabio ArtosiFlavia LozziClaudia FreniAlice RomeoEmi DikaMattia FalconiLuca BianchiPublished in: Pharmaceuticals (Basel, Switzerland) (2023)
Tirbanibulin is a viable therapeutic option with a short regimen treatment and good tolerability, which favors therapy adherence.